Caribou Biosciences (CRBU) $3.9M Investor Settlement
Caribou Biosciences reached an agreement with $CRBU investors to settle claims related to misleading about the CB-010's treatment effectiveness.
Case Details:
On December 12, 2022, Caribou issued a press release, which stated that Cohort 1 results show:
6 of 6 patients achieved a CR as the best response, 3 of 6 patients maintained a durable CR at 6 months, and 2 of 6 patients maintain a long-term CR at the 12-month scan and remain on the trial.
18 months is the longest CR maintained to date in ANTLER, achieved by the first patient dosed with CB-010 (Emphases added).
As a result, worries about how long the CB-010 treatment lasts were confirmed, even though Caribou had repeatedly said otherwise.
On this news, $CRBU fell over 9%.
Based on these events, Caribou was accused of the following details:
The effectiveness of CB-010's treatment didn't last as long as it was stated.
As a result, the clinical and commercial prospects of CB-010 were exaggerated.
Caribou Biosciences reached an agreement with $CRBU investors to settle claims related to the CB-010's treatment effectiveness.
Frequently Asked Questions
All persons who purchased or otherwise acquired the publicly traded securities of Caribou, during the period from July 23, 2021, through July 13, 2023, inclusive.
No, if you have purchased securities within the class period, you are eligible to participate.
You can participate in the settlement and retain (or sell) your securities.
The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration.
The final payout amount depends on your specific trades and the number of investors participating in the settlement.
If 100% of investors file their claims - the average payout will be $1.5 per share. Although typically only 25% of investors file claims, in this case, the average recovery will be $6 per share.
If you're eligible, you can file your claim directly from this case page by clicking the "Collect Payout" button.
More than 100 companies are currently paying out settlements. Connect your brokerage account to automatically check which ones you may have missed — or file manually for this case.
11thestate is an investor recovery company, we help investors to track and collect securities class action settlements. We will:
Prepare documents for your payout.
Audit the claim and make sure you get the maximum possible payout.
File a claim with the settlement administration.
Correspond with the settlement administration to resolve emerging issues.
Deliver payout directly to your brokerage account.
There is no upfront cost, but we will deduct 20% of the recovered amount as a commission for our services.